These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 108205)

  • 21. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA.
    Havelková H; Badalová J; Demant P; Lipoldová M
    Genes Immun; 2000 Dec; 1(8):483-7. PubMed ID: 11197689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iat epitopes on T cell receptor for self MHC class II determinants.
    Uracz W
    Folia Biol (Praha); 1988; 34(6):356-71. PubMed ID: 2470623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation of the immune response genes for LDH-B and MOPC-173. I. Description of an immune response defect in B10.BASR1.
    Gutmann DH; Allen PM; Niederhuber JE
    J Immunol; 1983 Dec; 131(6):2919-23. PubMed ID: 6417235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T lymphocyte response to minor H-43a alloantigen in H-43b mice. Privileged H-2Kb restriction to the response is not due to immunodominance or epistatic effect but due to Ir gene function of H-2Kb itself.
    Hino T; Ishikawa H; Saito K
    J Immunol; 1988 Jan; 140(1):44-51. PubMed ID: 3121741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic influences on the immune repertoire following tuberculous infection in mice.
    Brett SJ; Ivanyi J
    Immunology; 1990 Sep; 71(1):113-9. PubMed ID: 2120127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice.
    Capková J; Hasek M; Kousalová M; Holán V; Boubelík M
    Folia Biol (Praha); 1983; 29(2):200-8. PubMed ID: 6862049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic determination of the immune response of mice to cells of various histological types].
    Lavrovskiĭ VA; Viksler VKh; Iurchenko IuA; Razvorotnev VA
    Genetika; 1978; 14(1):72-80. PubMed ID: 627344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
    Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
    Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
    Peterson LB; Wilner GD; Thomas DW
    J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
    Burton RC; Warner NL
    Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene dose effects in Ir gene-controlled systems.
    Dorf ME; Stimpfling JH; Benacerraf B
    J Immunol; 1979 Jul; 123(1):269-71. PubMed ID: 109535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H-2-linked genetic control of resistance to histocompatible tumors.
    Williams RM; Dorf ME; Benacerraf B
    Cancer Res; 1975 Jun; 35(6):1586-90. PubMed ID: 805662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system].
    Schulze HA; Brock J
    Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.